Stereotaxis Inc — 貸借対照表 (NYSE:STXS) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 55.46 M60.98 M53.41 M41.91 M46.72 M52.25 M 負債合計 15.23 M21.56 M21.48 M19.99 M35.29 M33.53 M 純資産合計 34.62 M33.84 M26.35 M16.34 M6.08 M13.48 M 負債および純資産合計 55.46 M60.98 M53.41 M41.91 M46.72 M52.25 M 有利子負債合計 2.16 M0———— 純負債 -41.78 M-38.74 M————

ニュース

Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks (NYSE:STXS)

Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript

Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates

【決算速報】Stereotaxis、売上高は予想を下回り、利益は予想と一致する結果に

Stereotaxis earnings matched, revenue fell short of estimates

Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates

Can Digital Subscriptions Become ISRG's New Revenue Stream in 2026?

OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates

TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates

Beta Bionics, Inc. (BBNX) Reports Q4 Loss, Tops Revenue Estimates

FDAがシールド・セラピューティクスのACCRUFeRに3年間の追加独占権を付与

FDA grants additional 3-year exclusivity for Shield’s ACCRUFeR